Clinical Trials Browser

Interventional × Proteostasis Deficiencies × daratumumab × Clear all

NCT05451771 2025-07-08

Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis

Phase 1/2 Recruiting

Immunoglobulin Light-chain Amyloidosis, Proteostasis Deficiencies